Hirofumi Arakawa

7.4k citations
68 papers · 6.0k indexed · 2 hit papers · h-index 37
Topics
Cancer-related Molecular Pathways (31 papers)Cancer Research and Treatments (13 papers)Mitochondrial Function and Pathology (10 papers)

In The Last Decade

Hirofumi Arakawa

67 papers receiving 5.8k citations

Hit Papers

p53AIP1, a Potential Mediator of p53-Dependent Apoptosis,...200020262008201720002000250500750

Peers

Hirofumi Arakawa
Comparison fields: 5 of 114
  • Molecular Biology 4.2k
  • Oncology 2.5k
  • Cancer Research 1.1k
  • Cell Biology 498
  • Cellular and Molecular Neuroscience 451
Replace Margaret Ashcroft with:
Margaret Ashcroft United Kingdom
Joan Gil Spain
Xinbin Chen United States
Nathalie M. Mazure France
Sarah‐Maria Fendt Belgium
Peppi Koivunen Finland
Young‐Ah Suh South Korea
Keizo Takenaga Japan
Roland Stein United States
Ya‐Min Tian United Kingdom
Hirofumi Arakawa relative to Margaret Ashcroft United Kingdom Margaret Ashcroft's profile →
Citations per field
00.5×4.0×
Margaret Ashcroft · 1×
Citations per year

Countries citing papers authored by Hirofumi Arakawa

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Arakawa more than expected).

Fields of papers citing papers by Hirofumi Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Arakawa. The network helps show where Hirofumi Arakawa may publish in the future.

Co-authorship network of co-authors of Hirofumi Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Arakawa. A scholar is included among the top collaborators of Hirofumi Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Arakawa. Hirofumi Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 12
3 66
4 55
5 9
6 82
7 428
8 25
9 111
10 73
11 15
12 6
13 47
14 144
15 39
16 25
17 290
18
p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53breakdown →
977
19 90
20 4

About Hirofumi Arakawa

Hirofumi Arakawa is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 68 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (31 papers), Cancer Research and Treatments (13 papers) and Mitochondrial Function and Pathology (10 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.1k citations) and Molecular Biology (4.2k citations). Hirofumi Arakawa has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Koichi Matsuda, Seisuke Fukuda, Yoichi Taya, Toshiki Mori, Chizu Tanikawa, Yusuke Nakamura, Tomoaki Tanaka, Yusuke Nakamura, Tatsuya Yamaguchi and Kenji Shiraishi. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026